TP53 and adenocarcinoma: For example, chromosome 6 loss is observed in <2.5% of TP53-mutated myeloid tumors but is often detected in TP53-mutated solid tumors including ovarian (83%), pancreatic (61%), and esophageal (29%) adenocarcinomas.